Fluxapyroxad
CAS: 907204-31-3
Ref. 3D-FF103006
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar | ||
250mg | A consultar |
Informação sobre produto
- 1H-Pyrazole-4-carboxamide, 3-(difluoromethyl)-1-methyl-N-(3′,4′,5′-trifluoro[1,1′-biphenyl]-2-yl)-
- 3-(Difluoromethyl)-1-methyl-N-(3′,4′,5′-trifluoro[1,1′-biphenyl]-2-yl)-1H-pyrazole-4-carboxamide
- 3-(Difluoromethyl)-1-methyl-N-(3′,4′,5′-trifluorobiphenyl-2-yl)-1H-pyrazole-4-carboxamide
- 3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluoro[1,1'-biphenyl]-2-yl)-1H-pyrazole-4-carboxamide
- 3-(difluoromethyl)-1-methyl-N-(3',4',5'-trifluorobiphenyl-2-yl)pyrazole-4-carboxamide
- Acceleron DX 612
- Imbrex
- Sercadis
- Systiva XS
- T5Nnj A1 Cyff Dvmr Br Cf Df Ef
- Ver mais sinónimos
- Xemium
- Xzemplar
Fluxapyroxad is a prothioconazole-based fungicide. It has a pyrazole ring and functions as an inhibitor of fungal cell wall synthesis by blocking the enzyme polyketide synthase. Fluxapyroxad also has a synergic effect with other fungicides and can be used in vitro to inhibit the growth of fungi that are resistant to other antifungal agents. The analytical method is based on fluorescence detection, which allows for sensitive detection at low concentrations. Fluxapyroxad is toxic to both animals and humans, but it has been shown to have little or no effect on bacteria. This product is not registered for use in the United States.br>br>Fluxapyroxad's primary mode of action is to inhibit fatty acid biosynthesis through competitive inhibition of 3-hydroxyacyl coenzyme A reductase (HACR). In addition, fluxapyroxad inhibits protein synthesis by binding to ribos
Propriedades químicas
Consulta técnica sobre: 3D-FF103006 Fluxapyroxad
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.